Treatment of autoimmune liver disease: current and future therapeutic options. - Wikidata - awgldk - TriplyDB

Treatment of autoimmune liver disease: current and future therapeutic options.

Treatment of autoimmune liver disease: current and future therapeutic options.

http://www.wikidata.org/entity/Q34342199

about

Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis.Serum Cytokine Levels and Their Relation to Clinical Features in Patients with Autoimmune Liver Diseases.Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumab.Obeticholic acid for the treatment of primary biliary cirrhosis.Diagnosis and Treatment of Autoimmune Liver Diseases in a Tertiary Referral Center in Cuba.Therapeutic potential of phages in autoimmune liver diseases.The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis.

P2860

Q26796355-B44E20AC-B71D-40C0-A902-F93093B5F654 Q36089858-7CB71396-D619-4508-A912-6E51DE921A25 Q37680995-EE7959E2-E68D-47A8-BF0B-CF0634CF240B Q38608954-26096EDD-C062-47D6-90D0-92865D46BB47 Q38628470-A805AEC3-9AEB-4F81-B2EA-0AB75206A2EC Q44247097-21FFD477-0155-411F-BDD2-5987B294A9F5 Q47269751-D7BDAA9A-16CF-4F4A-B4EE-AEFE57ED8100 Q52733589-6F2A2C8F-D7A1-4FF8-99D3-1A9119B65558

P2860

Treatment of autoimmune liver disease: current and future therapeutic options.

http://www.wikidata.org/entity/Q34342199

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Treatment of autoimmune liver disease: current and future therapeutic options.

@ast

Treatment of autoimmune liver disease: current and future therapeutic options.

@en

Treatment of autoimmune liver disease: current and future therapeutic options.

@nl

type

label

Treatment of autoimmune liver disease: current and future therapeutic options.

@ast

Treatment of autoimmune liver disease: current and future therapeutic options.

@en

Treatment of autoimmune liver disease: current and future therapeutic options.

@nl

prefLabel

Treatment of autoimmune liver disease: current and future therapeutic options.

@ast

Treatment of autoimmune liver disease: current and future therapeutic options.

@en

Treatment of autoimmune liver disease: current and future therapeutic options.

@nl

P1433

Q34342199-C157C996-28C0-488D-904F-BD5FC54F0800

P1476

Q34342199-F8D4E333-1ED4-4113-8F1B-4EF5B2336FC7

P2093

Q34342199-A2B90256-7183-4238-BBEE-D0D7E2BB0748

P2860

Q34342199-01C1EFCC-A0F7-4194-BC95-23744F7B6D24

Q34342199-03FA8C2E-5516-46CD-8A17-1FFDC2DD776F

Q34342199-049F2E10-02D0-418B-8447-2390CF23F433

Q34342199-0B75F426-7129-48EB-BF91-F7102B294B84

Q34342199-0FD219E2-79F5-4F18-A253-C5FCFAA5F3D2

Q34342199-105FC9F3-DE58-47D3-BAED-E7B22A870580

Q34342199-12C6D72B-CDC7-4027-A2B3-2DC48B4E49A0

Q34342199-12E887D4-838A-471C-98C3-242C409BF0A5

Q34342199-1368DDDF-A27D-4A99-AC7B-4CBD6303A534

Q34342199-13C9F3FB-33FC-444D-9037-22B68398A258

P304

Q34342199-D0BD9268-0486-4EA0-A737-847E16139742

P31

Q34342199-E9146B16-D815-4A15-8FA4-254950DA9419

P356

Q34342199-0BFDEAC5-35BF-4939-AC18-5047B44A3204

P433

Q34342199-4561CB27-F9D4-4CBD-AACA-8668FE9A9588

P478

Q34342199-22D8C959-0EEF-463E-99EF-370291C622AE

P50

Q34342199-A5B72C70-D297-41CB-AC0D-530D19D61C55

P577

Q34342199-56B6F141-CC15-4F49-9474-95F88324850F

P698

Q34342199-991D050F-12C8-46C7-AC55-80F718C13843

P932

Q34342199-A7603F77-5D62-4E25-8DA3-4B8B3F494F97

P356

2040622313478646

P1433

Therapeutic advances in chronic disease

P1476

Treatment of autoimmune liver disease: current and future therapeutic options.

@en

P2093

Palak J Trivedi

http://www.w3.org/2001/XMLSchema#string

P2860

Bile acids for primary sclerosing cholangitis

Ursodeoxycholic acid for primary biliary cirrhosis

Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant

Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis

Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.

Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.

P304

119-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2040622313478646

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Gideon M. Hirschfield

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23634279

http://www.w3.org/2001/XMLSchema#string

P932

3629750

http://www.w3.org/2001/XMLSchema#string